Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

oscar

Rank: Vice President [?]

Points: 3670 [?]

Votes: 69 Score: 3.2 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Thanks, Cytoman

posted on Aug 08, 2007 01:49PM

Pohl David · 4 · Patriot Scientific Corp · For 8/6/07Filed On 8/8/07 5:24pm ET · SEC File 0-22182 · Accession Number 1019687-7-2456

			in	this filing.an "object" Search.	Show	docs searched	and	the 1st "hit".every "hit".
Help...	*Wildcards:* ? (any letter), * (many). *Logic:* for Docs: & (and), \| (or); for Text: \| (anywhere), "(&)" (near).

As Of Filer Filing As/For/On Docs:Pgs Issuer Agent 8/08/07 Pohl David 4 8/06/07 1:5 Patriot Scientific Corp Publicease Inc/FA

Statement of Change in Beneficial Ownership of Securities · Form 4
Filing Table of ContentsDocument/Exhibit Description Pages Size 1: 4 Statement of Change in Beneficial Ownership of XML 8K Securities

This is an EDGAR XML document rendered as filed.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Expires:	January 31, 2008
Estimated average burden
hours per response	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person*

POHL DAVID

(Last)

(First)

(Middle)

6183 PASEO DEL NORTE, SUITE 180

(Street)

CARLSBAD

92011

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PATRIOT SCIENTIFIC CORP [ PTSC.OB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/07

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

*Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned*
*1. Title of Security (Instr. 3)*	*2. Transaction Date (Month/Day/Year)*	*2A. Deemed Execution Date, if any (Month/Day/Year)*	*3. Transaction Code (Instr. 8)*	*4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)*	*5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)*	*6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)*	*7. Nature of Indirect Beneficial Ownership (Instr. 4)*
*Code*	V	*Amount*	*(A) or (D)*	*Price*
Common $.00001 par value	08/06/07		G		700,000	A	$0	900,000	D
Common $.00001 par value	08/06/07		M		1,000,000	A	$0.165	1,900,000	D
Common $.00001 par value	08/06/07		F		343,750	D	$0.48	1,556,250	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Stock Option (right to buy)

$0.165

08/06/07

1,000,000

06/05/06

08/15/07

Common $.00001 par value

1,000,000

500,000

Explanation of Responses:

Remarks:

	/s/ David Pohl	08/08/07
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

________ Transaction Codes:
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3.
G	Bona fide gift.
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.

Alternative Formats: Rich Text / Word (.rtf), Text (.txt), EDGAR (.sgml), XML (.xml), et al.

Reply New Message

Back To Forum List View

Please to post a reply